Trial record 1 of 1 for:    APC-10U1101
Previous Study | Return to List | Next Study

A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients (MuGard)

This study has been completed.
Information provided by (Responsible Party):
Access Pharmaceuticals, Inc. Identifier:
First received: January 25, 2011
Last updated: September 10, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
No publications provided by Access Pharmaceuticals, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):